Stockscreener 앱 받기
41.53
4.93%
1.95
전일 마감가:
$39.58
열려 있는:
$40.32
하루 거래량:
1.43M
Relative Volume:
0.78
시가총액:
$2.23B
수익:
-
순이익/손실:
$-38.99M
주가수익비율:
-13.86
EPS:
-2.9966
순현금흐름:
$-24.94M
1주 성능:
+7.70%
1개월 성능:
-9.99%
6개월 성능:
-48.85%
1년 성능:
-18.54%
1일 변동 폭
$39.55
$41.80
1주일 범위
$39.23
$44.70
52주 변동 폭
$37.95
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
명칭
Soleno Therapeutics Inc
전화
650-213-8444
주소
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Compare SLNO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
41.53 | 2.13B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.92 | 116.41B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
785.51 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
811.45 | 50.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.16 | 43.76B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
353.92 | 38.40B | 4.98B | 69.60M | 525.67M | 0.5198 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | Wolfe Research | Outperform |
| 2025-10-07 | 개시 | Goldman | Buy |
| 2025-08-20 | 개시 | Wells Fargo | Overweight |
| 2025-06-23 | 개시 | TD Cowen | Buy |
| 2025-03-05 | 재개 | Stifel | Buy |
| 2024-12-02 | 재확인 | Robert W. Baird | Outperform |
| 2024-12-02 | 재확인 | Stifel | Buy |
| 2024-09-03 | 개시 | H.C. Wainwright | Buy |
| 2024-05-10 | 개시 | Robert W. Baird | Outperform |
| 2024-02-05 | 개시 | Piper Sandler | Overweight |
| 2024-01-23 | 개시 | Stifel | Buy |
| 2023-11-21 | 재개 | Guggenheim | Buy |
| 2020-09-29 | 개시 | Guggenheim | Buy |
| 2020-01-10 | 개시 | Craig Hallum | Buy |
| 2019-12-23 | 개시 | Oppenheimer | Outperform |
| 2018-02-13 | 재확인 | Maxim Group | Buy |
모두보기
Soleno Therapeutics Inc 주식(SLNO)의 최신 뉴스
Pullback Watch: Why is Soleno Therapeutics Inc. stock going downMarket Growth Report & Fast Moving Market Watchlists - baoquankhu1.vn
Why a biotech is drawing attention to a rare disease at the Super Bowl - Medical Marketing and Media
(SLNO) Movement as an Input in Quant Signal Sets - Stock Traders Daily
VYKAT XR Launch Momentum Could Be A Game Changer For Soleno Therapeutics (SLNO) - Yahoo Finance
A Look At Soleno Therapeutics (SLNO) Valuation As VYKAT XR Launch Shapes A “Transformational” 2025 - Yahoo Finance
A Look At Soleno Therapeutics (SLNO) Valuation After VYKAT XR Launch And Upcoming 2025 Business Updates - Sahm
Published on: 2026-02-03 13:03:09 - baoquankhu1.vn
Soleno Therapeutics (NASDAQ:SLNO) Stock Price Up 8.3%Time to Buy? - MarketBeat
Soleno Therapeutics stock jumps nearly 9% today — what SLNO traders are watching next - TechStock²
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround - Yahoo Finance
Soleno Therapeutics, Inc. (SLNO) Stock Analysis: A Compelling 190% Upside Potential - DirectorsTalk Interviews
Universal Beteiligungs und Servicegesellschaft mbH Sells 32,627 Shares of Soleno Therapeutics, Inc. $SLNO - MarketBeat
Risk Hedge: Is Diebold Nixdorf Incorporated a good ESG investmentRate Cut & Precise Swing Trade Alerts - baoquankhu1.vn
Sell Signal: Will Soleno Therapeutics Inc outperform the market in YEAR2025 Key Highlights & Verified Swing Trading Watchlist - baoquankhu1.vn
Soleno Therapeutics stock hits 52-week low at 39.42 USD By Investing.com - Investing.com South Africa
Soleno Therapeutics Shares Dip Following $200 Million Stock Offering Pricing - MSN
Soleno Therapeutics (NASDAQ:SLNO) Hits New 52-Week LowShould You Sell? - MarketBeat
Soleno Therapeutics stock hits 52-week low at 39.42 USD - Investing.com
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN
Soleno Therapeutics to Participate in Upcoming Conferences - The Manila Times
Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Soleno Therapeutics (SLNO) - The Globe and Mail
Solena Therapeutics (SLNO) Stock Under Pressure But Upside is Huge - Finviz
Soleno Therapeutics (SLNO) Stock Analysis: Unveiling a Potential 164% Upside in the Biotech Arena - DirectorsTalk Interviews
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Liquidity Mapping Around (SLNO) Price Events - Stock Traders Daily
Soleno Therapeutics Updates Executive Compensation and Severance Plans - The Globe and Mail
Is Soleno Therapeutics, Inc. (NASDAQ:SLNO) The Best Under $50 Stock to Buy Now? - Insider Monkey
Emerald Mutual Fund Advisers Trust Reduces Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
Soleno Therapeutics Inc. (SLNO): Analysts See Major Upside - Finviz
Soleno Therapeutics (SLNO) Valuation Checked After New Q4 2025 Revenue Guidance - Sahm
FY2025 Earnings Estimate for SLNO Issued By HC Wainwright - MarketBeat
Emerald Advisers LLC Trims Position in Soleno Therapeutics, Inc. $SLNO - MarketBeat
SLNO INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving Soleno Therapeutics, Inc. - ACCESS Newswire
Q2 EPS Estimate for Soleno Therapeutics Increased by Analyst - MarketBeat
Soleno Therapeutics stock price target raised to $120 from $110 at H.C. Wainwright - Investing.com Nigeria
Soleno Therapeutics stock price target raised to $120 from $110 at H.C. Wainwright By Investing.com - Investing.com South Africa
Soleno Therapeutics (SLNO): Wells Fargo Raises Price Target to $114 | SLNO Stock News - GuruFocus
Johnson Fistel Begins Investigation on Behalf of Soleno - GlobeNewswire
Wells Fargo Maintains Soleno Therapeutics(SLNO.US) With Buy Rating, Raises Target Price to $114 - 富途资讯
Soleno Therapeutics (SLNO) may find a bottom soon, here's why you should buy the stock now - MSN
Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Exploring A 160% Potential Upside - directorstalkinterviews.com
SLNO INVESTOR ALERT: Investors Encouraged to Contact Kirby McInerney LLP About Fraud Investigation - GlobeNewswire
Momentum Shift: What is Soleno Therapeutics Incs revenue forecast2025 Year in Review & Consistent Growth Equity Picks - baoquankhu1.vn
Market Outlook: Is Soleno Therapeutics Inc forming a breakout patternJuly 2025 Momentum & Long Hold Capital Preservation Plans - baoquankhu1.vn
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid - GlobeNewswire
Soleno Therapeutics (SLNO) Faces Investor Scrutiny Amid Disappointing VYKAT XR Starts, Discontinuations; Shares Down 26% -- Hagens Berman - GlobeNewswire Inc.
Dow Update: Is Monogram Technologies Inc trading at a discountWeekly Stock Summary & Precise Entry and Exit Recommendations - baoquankhu1.vn
Q4 EPS Estimate for Soleno Therapeutics Increased by Analyst - MarketBeat
Soleno Therapeutics (SLNO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - Finviz
Soleno Therapeutics Inc (SLNO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.23%
1.25%
자본화:
|
볼륨(24시간):